Latest News

July 11, 2002
In Zimbabwe, rape is all too common and negotiating safe sex to prevent infection with HIV is almost impossible for many adolescent girls because involvement with older men in return for material benefits is widespread, according to researchers from UCSF.
July 11, 2002
BARCELONA - Growth hormone may stimulate the production of T cells in HIV-infected patients, research at the Gladstone Institute of Virology and Immunology shows. T cells are the immune system cells that HIV attacks and destroys, leaving patients without defenses against the opportunistic infections of AIDS. Laura Napolitano, MD, lead investigator of the study, presented the research on July 11 at the 14th International AIDS Conference here in Barcelona. Napolitano is a staff research investigator at Gladstone and UCSF assistant professor of medicine.
July 11, 2002
Three percent of HIV-infected gay men in New York and San Francisco had a current syphilis infection, half of one percent had a current case of chlamydia or gonorrhea when tested between 2000-2001, according to UCSF researchers.
July 09, 2002
Almost all (98 percent) Zimbabwean women who were unable to persuade their male partners to use condoms consistently, used the diaphragm as an alternative method of contraception and disease prevention, though its effectiveness against HIV remains unknown, UCSF researchers have found.
July 08, 2002
Young gay men-ages 18 to 28-in Albuquerque reported a 12% decrease in risky sexual behavior as a result of a community building HIV prevention intervention. Similar cohorts in Austin and Phoenix who did not receive the intervention reported increases of 42% and 26% respectively, when compared to risky behavior rates prior to the introduction of HAART (Highly Active Anti-Retroviral Therapy) in 1996, say researchers at UCSF’s Center for AIDS Prevention Studies (CAPS).
July 08, 2002
UCSF Family and Community Medicine faculty members have responded to more than 50,000 calls from health care workers across the country seeking information from the National HIV Telephone Consultation Service (Warmline) and the National Clinicians’ Post-Exposure Prophylaxis Hotline (PEPline). The services are provided through the National HIV/AIDS Clinicians’ Consultation Center (NCCC), a joint collaboration between the UCSF Department of Family and Community Medicine, the Health Resources and Services Administration (HRSA), and the CDC.
July 08, 2002
WHAT A celebration of the Avon Foundation’s gifts of $12.2 million (to-date) to the partnership between San Francisco General Hospital Medical Center (SFGHMC) and University of California, San Francisco (UCSF) The UCSF digital Mammovan, supported in part by Avon funds, will be available for tours at approximately 11:30 on the street at 401 Van Ness WHERE Veteran’s Building at 401 Van Ness Ave, San Francisco Green Room, second floor WHEN 10:30 am - noon Wednesday (July 10) Program begins at 11 am (See detailed schedule, below)
July 06, 2002
A rising number of San Franciscans are being infected with HIV that is already resistant to some classes of antiretroviral drugs, report researchers from the Gladstone Institute of Virology and Immunology in the July 10th issue of the Journal of the American Medical Association.
July 02, 2002
Although therapy with hormones was once thought to protect women’s hearts after menopause, a UCSF-led study has found that, at least for women with heart disease, estrogen plus progestin therapy does not reduce the risk of heart attack or death. The July 3, 2002 issue of the Journal of the American Medical Association (JAMA) contains two articles with the results of the Heart and Estrogen/Progestin Replacement Follow-up Study (HERS II).
July 01, 2002
A class of once-popular high blood pressure drugs, now used less frequently because of serious side effects, may be re-explored in light of San Francisco Veterans Affairs Medical Center research. The new study in mice suggests that drugs which block just one type of adrenalin receptor might be just as effective as the earlier, related drugs, but with fewer side effects.  The earlier drugs block more types of adrenalin receptors.